Novo Nordisk to sell its stake in Dako AS for 1.5 bln dkr |
|
|
|
Published
:
Wed, 28 Feb 2007 10:44
|
COPENHAGEN (AFX) - Novo Nordisk AS said it will sell its 27 pct stake in cancer diagnostics group Dako AS to private equity fund EQT V for an expected sum of 1.5 bln dkr.The board of directors of Dako AS has decided today to divest its only subsidiary Dako Denmark AS to EQT V, Novo Nordisk said, adding the sales agreement is subject to approval by applicable competition authorities and the approval by a shareholders' meeting of Dako AS.'As one of the main shareholders we are pleased that an attractive ownership solution has been found for Dako, which will facilitate the continued expansion of the company's business activities,' Novo Nordisk chief financial officer Jesper Brandgaard said.gustav.sandstrom@thomson.comgs/amCOPYRIGHTCopyright AFX News Limited 2007. All rights reserved.The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.AFX News and AFX Financial News Logo are registered trademarks of AFX News Limited
|
|
|
|
Print this Story
Copenhagen shares AFX At a glance 